Educational information, not medical advice — ask your doctor or midwife.
Bakuchiol is a natural meroterpene compound found in the seeds and leaves of the Babchi plant, long used in Ayurvedic and traditional Chinese medicine for skin health. In modern skincare, it's formulated into serums, oils, and moisturizers as a plant-based alternative to vitamin A retinoids. What makes it special is that it appears to work through similar pathways to retinol — stimulating collagen and smoothing skin — but is far less likely to cause dryness, peeling, or sun sensitivity.
Bakuchiol activates retinol-like receptors in skin cells, encouraging collagen production and speeding up healthy cell turnover — the two key processes that make skin look firmer and more even. Unlike retinol, it doesn't disrupt the skin's barrier or cause the initial 'retinization' period of redness and flaking. It also has antioxidant and anti-inflammatory properties that help calm skin while it renews.
Serums are the most common and best-studied delivery format for bakuchiol, offering higher active concentrations. Face oils, moisturizers, and eye creams are also available and often combine bakuchiol with complementary ingredients like niacinamide, hyaluronic acid, or vitamin C. Oral bakuchiol supplements exist but have no published clinical skin trials; all evidence comes from topical use.
Babchi seeds have been used in Ayurvedic medicine for over a thousand years, primarily for skin conditions like vitiligo, psoriasis, and infections. Korean and Chinese traditional medicine also incorporated the plant for inflammatory skin diseases. The modern isolation of bakuchiol as a cosmetic active began around 2007 and gained mainstream attention after a landmark 2019 head-to-head trial comparing it directly to retinol.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.